Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 408

1.

Dual phenotypic transmission in Brugada syndrome.

Hermida JS, Arnalsteen-Dassonvalle E, Kubala M, Mathiron A, Traulle S, Anbazhagan K, Hermida A, Rochette J.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):366-72. doi: 10.1016/j.acvd.2013.04.007. Epub 2013 Jun 28.

2.

Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.

Pambrun T, Mercier A, Chatelier A, Patri S, Schott JJ, Le Scouarnec S, Chahine M, Degand B, Bois P.

Heart Rhythm. 2014 Aug;11(8):1393-400. doi: 10.1016/j.hrthm.2014.04.026. Epub 2014 Apr 21.

PMID:
24768612
3.

Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.

Wahbi K, Algalarrondo V, Bécane HM, Fressart V, Beldjord C, Azibi K, Lazarus A, Berber N, Radvanyi-Hoffman H, Stojkovic T, Béhin A, Laforêt P, Eymard B, Hatem S, Duboc D.

Arch Cardiovasc Dis. 2013 Dec;106(12):635-43. doi: 10.1016/j.acvd.2013.08.003. Epub 2013 Oct 17.

4.

Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.

Gandjbakhch E, Fressart V, Duthoit G, Marquié C, Deharo JC, Pousset F, Hebert JL, Simon F, Himbert C, Klug D, Charron P, Hidden-Lucet F.

Int J Cardiol. 2014 Mar 1;172(1):256-8. doi: 10.1016/j.ijcard.2013.12.269. Epub 2014 Jan 10. No abstract available.

5.

Brugada syndrome with a novel missense mutation in SCN5A gene: a case report from Bangladesh.

Sayeed MZ, Salam MA, Haque MZ, Islam AK.

Indian Heart J. 2014 Jan-Feb;66(1):104-7. doi: 10.1016/j.ihj.2013.12.003. Epub 2013 Dec 26.

6.

A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.

Zumhagen S, Veldkamp MW, Stallmeyer B, Baartscheer A, Eckardt L, Paul M, Remme CA, Bhuiyan ZA, Bezzina CR, Schulze-Bahr E.

PLoS One. 2013 Jun 28;8(6):e67963. doi: 10.1371/journal.pone.0067963. Print 2013.

7.

A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome.

García-Molina E, Lacunza J, Ruiz-Espejo F, Sabater M, García-Alberola A, Gimeno JR, Cañizares F, García A, Martínez P, Valdés M, Tovar I.

Clin Genet. 2013 Jun;83(6):530-8. doi: 10.1111/cge.12017. Epub 2012 Oct 16.

PMID:
22984773
8.

p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.

Hothi SS, Ara F, Timperley J.

J Cardiovasc Electrophysiol. 2015 Jan;26(1):93-7. doi: 10.1111/jce.12470. Epub 2014 Jul 23.

PMID:
24903439
9.

Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.

Calloe K, Refaat MM, Grubb S, Wojciak J, Campagna J, Thomsen NM, Nussbaum RL, Scheinman MM, Schmitt N.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):177-84. doi: 10.1161/CIRCEP.112.974220.

10.

[Genetic and molecular basis for sodium channel-mediated Brugada syndrome].

Barajas-Martínez H, Hu D, Antzelevitch C.

Arch Cardiol Mex. 2013 Oct-Dec;83(4):295-302. doi: 10.1016/j.acmx.2013.10.001. Epub 2013 Nov 21. Review. Spanish.

PMID:
24269159
11.

Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience.

Wong LC, Roses-Noguer F, Till JA, Behr ER.

Circ Arrhythm Electrophysiol. 2014 Oct;7(5):800-6. doi: 10.1161/CIRCEP.114.001818. Epub 2014 Sep 6.

12.

Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation.

Hong K, Hu J, Yu J, Brugada R.

Eur J Hum Genet. 2012 Nov;20(11):1189-92. doi: 10.1038/ejhg.2012.63. Epub 2012 Apr 11.

13.

Long QT and Brugada syndrome gene mutations in New Zealand.

Chung SK, MacCormick JM, McCulley CH, Crawford J, Eddy CA, Mitchell EA, Shelling AN, French JK, Skinner JR, Rees MI.

Heart Rhythm. 2007 Oct;4(10):1306-14. Epub 2007 Jul 14.

PMID:
17905336
14.

Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.

Santos LF, Rodrigues B, Moreira D, Correia E, Nunes L, Costa A, Elvas L, Pereira T, Machado JC, Castedo S, Henriques C, Matos A, Santos JO.

Europace. 2012 Jun;14(6):882-8. doi: 10.1093/europace/eur421. Epub 2012 Jan 25.

PMID:
22277643
15.

Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.

Maury P, Moreau A, Hidden-Lucet F, Leenhardt A, Fressart V, Berthet M, Denjoy I, Bennamar N, Rollin A, Cardin C, Guicheney P, Chahine M.

J Interv Card Electrophysiol. 2013 Aug;37(2):131-40. doi: 10.1007/s10840-013-9805-7. Epub 2013 Apr 24.

PMID:
23612926
16.

[Clinic and genetic polymorphism of Brugada syndrome in Russian patients, caused by mutation in SCN5A gene].

Zakliaz'minskaia EV, Shestak AG, Revishvili ASh, Pronicheva IV, Podoliak DG, Nechaenko MA, Poliakov AV, Dzemeshkevich SL.

Khirurgiia (Mosk). 2013;(2):49-53. Russian.

PMID:
23503384
17.

Brugada syndrome: two decades of progress.

Veerakul G, Nademanee K.

Circ J. 2012;76(12):2713-22. Epub 2012 Nov 14. Review.

18.

Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.

Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, Guerchicoff A, Matsuo K, Burashnikov E, Dumaine R, Towbin JA, Nesterenko V, Brugada P, Antzelevitch C, Brugada R.

Circulation. 2004 Nov 9;110(19):3023-7. Epub 2004 Nov 1.

19.

Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:.

Hong K, Berruezo-Sanchez A, Poungvarin N, Oliva A, Vatta M, Brugada J, Brugada P, Towbin JA, Dumaine R, Piñero-Galvez C, Antzelevitch C, Brugada R.

J Cardiovasc Electrophysiol. 2004 Jan;15(1):64-9.

PMID:
15028074
20.

Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?

Yildiz BS, Gungor H, Gul I, Bilgin M, Zoghi M, Akilli A.

Cardiovasc J Afr. 2013 Mar 23;24(2):e4-6. doi: 10.5830/CVJA-2012-068.

Supplemental Content

Support Center